Kimberly Parker+FollowMore women are getting lung cancer without ever smoking. This is so crazy.I just read something that really shocked me. Doctors are seeing more and more non-smokers, especially women, with lung cancer. It's so scary because when a non-smoker gets diagnosed, it's often in the later stages. It happened to a woman named Katie who was only 37. She went to the doctor for a bad cough, thinking it was just asthma, but it turned out to be stage 4 lung cancer. 😱🤦😦 A cough that won't go away is a subtle symptom that a lot of people probably ignore. It just goes to show you don't have to be a smoker to be at risk. Things like radon gas in homes, air pollution, and even secondhand smoke can all be risk factors. I had no idea before... #HealthAwareness #LungCancer #Health #WomensHealth #PublicHealth 02Share
April Anderson+FollowNew FDA-Approved Lung Cancer Drug Alert!Big news for lung cancer patients: the FDA just greenlit Boehringer Ingelheim’s new drug, Hernexeos, for those with a specific genetic mutation who’ve already had treatment. In trials, about 75% of patients saw their tumors shrink or disappear! There’s a new test to see if you qualify, but heads up—there are some serious side effects to watch for. Still, this could be a total game-changer for many! #Health #BodyHealth #LungCancer17213Share
Ryan Lewis+FollowThis green light tech is changing lung cancer surgerySurgeons in New Jersey are now using a groundbreaking green light drug, Cytalux, to spot and remove tiny lung cancer lesions that used to go unnoticed. This means doctors can save more healthy lung tissue and catch cancer at its earliest stages—potentially stopping it from coming back. Patients like Amy Demurjiam, who thought she just had allergies, are now breathing easier after surgery with this new tech. Cytalux is already approved for lung and ovarian cancer, and it’s being tested for even more uses. Imagine how many lives could change if this becomes standard care! What do you think about these advances? #Health #BodyHealth #LungCancer372Share
wilsonjames+FollowAllergies: An Unexpected Cancer Shield?Wild twist: Having allergies like hay fever or eczema might actually cut your lung cancer risk by 25%! Scientists dug through data from millions and found allergy sufferers—especially men with hay fever—were less likely to get lung cancer. The reason? Still a mystery, but it could be that allergies make your immune system extra vigilant. Who knew sneezing fits could have a silver lining? More research is needed, but this could change how we think about allergies and cancer risk. #Health #BodyHealth #LungCancer220Share
Michelle Welch+FollowGame-Changer for Lung Cancer FightersBig news for anyone battling advanced lung cancer: Datroway just got FDA approval as a new targeted treatment for people with EGFR-mutated non-small cell lung cancer (NSCLC) who’ve already tried other therapies. This drug acts like a smart missile, homing in on cancer cells and sparing more healthy ones. In trials, nearly half of patients saw their tumors shrink! If you or someone you know is running out of options, this could be a real breakthrough. Definitely worth asking your doctor about. #Health #BodyHealth #LungCancer80Share
Michelle Welch+FollowNew Hope for Rare Lung CancerBig news for anyone following cancer breakthroughs: the FDA just approved IBTROZI, a next-gen oral drug for advanced ROS1-positive non-small cell lung cancer. This rare type mostly hits younger, non-smokers and often spreads to the brain. IBTROZI showed super high response rates—even for those with brain metastases—and is generally well tolerated. With this approval, patients finally have a promising new option that could really change the game! #LungCancer #FDAApproval #CancerResearch #Health #BodyHealth50Share
wilsonjames+FollowNew Lung Cancer Pill Gets FDA Green LightBig news for lung cancer treatment! The FDA just approved Nuvation Bio’s new once-a-day pill, Ibtrozi, for people with ROS1-positive non-small cell lung cancer. This is a rare type, but the new drug could be a game-changer for those who need more options. Love seeing progress like this in cancer care! #LungCancer #FDAApproval #CancerResearch #Health #BodyHealth513Share
shermandarlene+FollowLung Cancer Breakthroughs You Need to KnowMajor news for small cell lung cancer: new immunotherapy combos are giving patients real hope for the first time in years! Adding the chemo drug lignin to atezolizumab can give patients three extra months without cancer getting worse. Even more exciting, a new drug called Imdelltra is helping people live over a year—way up from the usual 6-9 months. Plus, these new treatments come with fewer nasty side effects, and more patients (even those with brain mets) can join clinical trials. The future is looking brighter! #LungCancer #Immunotherapy #CancerResearch #Health140Share
Aaron Rodriguez+FollowLung Cancer Drug Shrinks Tumors Fast!Big news for lung cancer treatment: Tagrisso (osimertinib) is showing way more tumor shrinkage before surgery than chemo alone for patients with EGFR mutations. In a new study, about 1 in 4 patients saw major tumor reduction with Tagrisso (either solo or with chemo), compared to just 2% with chemo alone. This could mean better outcomes and more hope for early-stage lung cancer patients. Definitely a game-changer to ask your doctor about if you or someone you know is facing this diagnosis! #LungCancer #CancerResearch #Tagrisso #Health894Share
Michelle Welch+FollowGame-Changer for Lung Cancer?Big news in cancer treatment: Amgen’s new drug Imdelltra just cut the risk of death by 40% for small cell lung cancer patients compared to regular chemo! Patients lived over 5 months longer on average, and had fewer serious side effects (27% vs 62%). Plus, people felt better—less coughing and shortness of breath. These results could lock in FDA approval for Imdelltra. Feels like a huge win for patients and families facing this tough diagnosis. #LungCancer #MedicalBreakthrough #CancerResearch #Health10Share
